Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.


TSXV:COV - Post by User

Bullboard Posts
Comment by zenvestingon Oct 12, 2017 2:57pm
131 Views
Post# 26805950

RE:RE:RE:RE:RE:RE:MediClear Pre-Op Will Be A Home Run

RE:RE:RE:RE:RE:RE:MediClear Pre-Op Will Be A Home RunWe could only speculate what a licensing deal would look like....big up front payment and low royalty rates, or no upfront payment, some development milestone payments, and a high royalty percentage. Also, could Mediclear be bundled with Surgiclear to offer a bundled solution for pre-op to post-op? Wh knows? All I know is that after we got to claw back IV Clear & Surgiclear from Molnlycke after their poor sales performance for the first two years, I have confidence this team knows how to structure a deal in our best interest.
Bullboard Posts